Charles Persinger is an Executive Director in R&D Strategy at Eli Lilly and leads their Decision Sciences group. He joined Lilly after receiving his MBA from Duke University. Charles has over 20 years of experience helping enable organization decision quality at Lilly, with a focus on drug development and portfolio management decisions within Research and Development. He and the Decision Science team at Lilly work directly with decision-makers and drug development teams to enable decision quality across the R&D organization through a combination of direct decision consulting, developing and enabling decision processes, and education efforts. Lilly was awared the Raiffa-Howard Award for Organizational Decision Quality by the Society of Decision Professionals in 2016 and Charles was Co-Chair of the SDP Annual Conference in 2021.